The seller of the brain-cancer drug Gleostine has pulled out of a federal discount program for Medicare patients, leaving some struggling to pay for a therapy that can cost as much as $1,000 per capsule.
Patients may seek financial assistance from Nextsource or third-party sources, and doctors can explore less-expensive treatment alternatives. However, the company’s move highlights the limits of federal actions to reduce drug prices as well as programs meantUnder federal law, drug companies must provide certain discounts to be eligible for reimbursement by the Medicare Part D drug benefit.
NextSource says it hasn’t denied any patients’ applications for assistance and isn’t aware of any issues with access to its product. The society also sent a letter to NextSource CEO Robert DiCrisci in February, urging the company to rejoin Part D. The society shared a copy of the letter with The Wall Street Journal. NextSource didn’t respond to the letter, said a spokesman for the society.
An investigation by the Journal in 2017 showed how NextSource repeatedly hiked Gleostine prices, sparking outrage from doctors and patientsIn 2019, Medicare issued two fines to NextSource, totaling $117,206, for the company’s alleged failure to pay its share of drug costs under Part D within the required time frame in late 2018 and early 2019, according to letters the agency posted online. NextSource paid the penalties, a spokesman for the Medicare agency said.
Several of the nearly 40 study sites have had difficulty enrolling patients because of Gleostine’s cost, said Ashley Powell, director of the trial’s operations. The organization is having discussions with NextSource to address the issue, Ms. Powell said. NextSource confirmed the discussions.
America the richest 2nd or chest country on earth have many such costly pill, cancer, hep C, these medications ate beyond the reach of many, in should not be like this, Bernie Sanders is right.
I hope I never get truly sick in this godforsaken country.
It the state responsibility to care for their citizens Health, Big pharmaceutical making trillions, the lobbies pressuring lawmakers for not intervention. People suffering from Cancer are on a time Bomb, pharma companies pressuring the trigger with prices Enough is Enough
Time to start a healthy life of whole food plant based nutrition and a regular exercise regime. Stay away from pharmaceuticals.
As if a diagnosis of brain cancer is not devestating enough. Treatment drug Gleostine was dropped from part D coverage now $1k+ per pill. Company was bought out then price jacked Medicare discount eliminated. Greedy. Big Pharma. Criminals. Eliminate the $ buying votes/protection
Sad days in America when profit is more important than culture….Oh well,
The poor health of a human should not be a profit opportunity for some rich asshole.
Anpu_sk Which stock is going up in exchange for this suffering?
Why.?
Meanwhile our government sends billions of dollars to foreign countries in aide. every year. Disgusting AmericansFirst 🇺🇸
So on brand for American iNsuRaNCe
Big Pharma oh how we love you 😑
Oh this is GOOD!!!
Perhaps the problem is $1000 a pill...
Yeah but at least a few people at the top get more money. Doesn't that make it worth it?
Never depends on a single income Start earning daily or weekly with your phone or computer. Ask me (How) Dm me now
Only in America, putting people last when it comes to drug cost. Pharmaceuticals are worth millions they will never be able to spend. Give the people who really need that medication a break. Doesn’t cost hundred to make one pill.
The equivalent of $1.25 in Asia probably.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: WSJ - 🏆 98. / 63 Read more »
Source: PreventionMag - 🏆 141. / 63 Read more »
Source: BuzzFeed - 🏆 730. / 51 Read more »
Source: WSJ - 🏆 98. / 63 Read more »
Source: WSJ - 🏆 98. / 63 Read more »
Source: WSJ - 🏆 98. / 63 Read more »